COVID-19 crisis: Phase-II human trials for Bharat Biotech COVAXIN vaccine to begin in September

As India races against time to bring a safe and efficient anti-coronavirus vaccine made indigenously within the country, phase 1 of the human trials in most centers chosen for COVAXIN trials have concluded, India Today TV has learnt. The centers are now bracing for recruitment of candidates for phase 2 human trials, which are scheduled to begin in the first week of September.
Except for AIIMS Delhi - one of the 12 centers for the Bharat Biotech vaccine - where phase 1 trials are still underway, most of the other 11 centers have completed the process. AIIMS Delhi has only recruited 16 candidates for the vaccine human trials phase 1.